Construction and Validation of T‐cell Exhaustion‐related Gene Signature for Predicting Prognosis in Diffuse Large B-cell Lymphoma

The TEX score has prognosis-predicting value for DLBCL and might be a valuable biomarker to guide clinical decision-making for patients with DLBCL.

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Biotechnology
Published
2025-03-20
DOI
https://doi.org/10.2174/0113892010355990250310064916
Citations
2
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Construction and Validation of T‐cell Exhaustion‐related Gene Signature for Predicting Prognosis in Diffuse Large B-cell Lymphoma

Lixin Lv, Jie Zhou, Aibin Liang
2 citations
Current Pharmaceutical Biotechnology
Lymphoma Diagnosis and Treatment
2.94
article

Construction and Validation of T‐cell Exhaustion‐related Gene Signature for Predicting Prognosis in Diffuse Large B-cell Lymphoma

Lixin Lv, Jie Zhou, Aibin Liang
article en
2 citations

Abstract

The TEX score has prognosis-predicting value for DLBCL and might be a valuable biomarker to guide clinical decision-making for patients with DLBCL.

Current Pharmaceutical BiotechnologyVol. 26(16)
Tongji University (CN), Tongji Hospital (CN)
Openalex Percentile: Top 11%
Lymphoma Diagnosis and Treatment
2.94
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.